|
Segment Information (Schedule Of Product Sales) (Details) (USD $)
In Thousands, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2011
|
Dec. 31, 2010
|
Dec. 31, 2009
|
|
| Segment Reporting Information [Line Items] | |||
| Product sales | $ 8,102,359 | $ 7,389,921 | $ 6,469,311 |
|
AmBisome [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 330,156 | 305,856 | 298,597 |
|
Letairis [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 293,426 | 240,279 | 183,949 |
|
Ranexa [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 320,004 | 239,832 | 131,062 |
|
Other Products [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 109,057 | 66,956 | 16,829 |
|
Antiviral Products [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 7,049,716 | 6,536,998 | 5,838,874 |
|
Antiviral Products [Member] | Atripla [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 3,224,518 | 2,926,579 | 2,382,113 |
|
Antiviral Products [Member] | Truvada [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 2,875,141 | 2,649,908 | 2,489,682 |
|
Antiviral Products [Member] | Viread [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 737,867 | 732,240 | 667,510 |
|
Antiviral Products [Member] | Hepsera [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 144,679 | 200,592 | 271,595 |
|
Antiviral Products [Member] | Complera [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | 38,747 | 0 | 0 |
|
Antiviral Products [Member] | Emtriva [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Product sales | $ 28,764 | $ 27,679 | $ 27,974 |